×

NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS

  • US 20120183600A1
  • Filed: 01/04/2012
  • Published: 07/19/2012
  • Est. Priority Date: 01/16/2007
  • Status: Abandoned Application
First Claim
Patent Images

1. A composition comprising:

  • (a) an effective amount of a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5′

    -monophosphate-activated protein kinase (AMPK) activator;

    (b) an effective amount of a second agent that possesses anti-inflammatory activity; and

    (c) an effective amount of a third agent that possesses or maintains serotonin activity.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×